Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
This page offers a quick comparison of Index Fund and Target Date for retirement, with tips on matching your plans and risk tolerance.
23,996 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
As markets swing on inflation relief and rate expectations, a well-known consumer staples leader sits at a bargain, o...
Trump argues against rate hikes amid a stubborn inflation backdrop, while Kevin Warsh appears set to influence a hawk...
Kalshi and Polymarket have launched a coordinated policy crackdown on paid influencers promoting election fraud claim...
A federally funded health study tied to the Biden administration finds no safe level of alcohol and warns risks rise ...
Whales are stepping in to buy the dip as Dogecoin dips to a 14-month low. On-chain data shows a notable uptick in lar...
Figure Technology Solutions is acquiring Kiavi in a $717 million deal, expanding its first-lien lending and investor-...
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
A key on-chain signal points to a potential drop toward $700 for ethereum (eth), even as network activity grows and i...
Trading activity in the largest non-stablecoin crypto assets cooled to two-year lows as investors sit on the sideline...
XRP sentiment has slid to multi-month lows as traders await catalysts, but analysts warn that the worst periods can p...
A wave of AI adoption is shifting from hype to daily practice, with firms treating AI as a strategic partner and buil...